Friday, August 13, 2021 7:08:01 PM
C-20 just nailed it.
Analogy time. I know the man the broke all records racing a classic. 0 to 60 times shocking. It defeated every American auto at the Portland legal 1/4 mile track. Including Vipers, Vettes to the year 1999, even a Mad Max replica. That was cool.
What if the judges said; hey dude, your car is so quick we will only allow you to use the accelerator for the first 1/8 mile. Then you need to coast with built up forward motion to the 1/4 finish line.
How would that end?
That is exactly what the FDA of these United States did. Injection 1 on day 1. I believe injection 2 was on the 7th or 8th day. No injections allowed after 14 days. BUT the trial end point was 28 days. Do readers realize this inconvenient fact? The short narrative holds no water.
This was a travesty. Brazil is going to Blow the Doors Off.
Many know it. Many are frightened knowing that the day of total destruction to short sellers is coming. This story will be epic.
CYDY and the Miracle Drug. Coming to a Theater near you. Any small position holder can become very wealthy. 100, 500, 1000 shares. Any number can make a huge difference
Analogy time. I know the man the broke all records racing a classic. 0 to 60 times shocking. It defeated every American auto at the Portland legal 1/4 mile track. Including Vipers, Vettes to the year 1999, even a Mad Max replica. That was cool.
What if the judges said; hey dude, your car is so quick we will only allow you to use the accelerator for the first 1/8 mile. Then you need to coast with built up forward motion to the 1/4 finish line.
How would that end?
That is exactly what the FDA of these United States did. Injection 1 on day 1. I believe injection 2 was on the 7th or 8th day. No injections allowed after 14 days. BUT the trial end point was 28 days. Do readers realize this inconvenient fact? The short narrative holds no water.
This was a travesty. Brazil is going to Blow the Doors Off.
Many know it. Many are frightened knowing that the day of total destruction to short sellers is coming. This story will be epic.
CYDY and the Miracle Drug. Coming to a Theater near you. Any small position holder can become very wealthy. 100, 500, 1000 shares. Any number can make a huge difference
Recent CYDY News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
